ArticleBMC nephrology2026
National dialysis registry of the Dominican Republic: first nationwide epidemiological analysis of renal replacement therapy.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney failure is a growing global health concern, affecting 9-10% of the population and contributing to rising mortality. In the Dominican Republic, a national dialysis registry was created in 2020 to monitor patients receiving kidney replacement therapy (KRT). Yet no comprehensive national epidemiological report has been published to date.
methodsWe conducted a nationwide, cross-sectional study using data from the 2022 Dominican National Dialysis Registry, encompassing all patients, both private and public, on hemodialysis (HD) or peritoneal dialysis (PD) in National Health Service, authorized units. Data were collected via a standardized digital form (August-September 2023) and analyzed using IBM SPSS Statistics v22.
resultsA total of 4,690 patients were recorded, median age 56 years (SD ± 15.6), 69% male. HD predominated (78.4%). Hypertension (93.9%) and diabetes mellitus (44.4%) were the most frequent comorbidities, with diabetes more common in PD than HD (52.5% vs. 42.2%). In HD, arteriovenous fistula was the primary access (61.2%); in PD, continuous ambulatory peritoneal dialysis (CAPD) was predominant (80.4%). National prevalence reached 421.8 patients per million population (91.1 ppm PD, 330.7 ppm HD), a 6% increase from 2022.
conclusionsThis first nationwide analysis provides a comprehensive characterization of the epidemiological profile of KRT in the Dominican Republic, revealing the dominance of HD, the high burden of cardiovascular and metabolic comorbidities, and rising prevalence rates. These findings underscore the urgent need to strengthen kidney failure prevention, improve early detection, and enhance the integration of PD within a balanced renal care strategy aligned with regional best practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.